Results 181 to 190 of about 75,178 (323)

Development and evaluation of a machine learning model to predict acute care for opioid use disorder among Medicaid enrollees engaged in a community‐based treatment program

Addiction, Volume 120, Issue 9, Page 1780-1789, September 2025.
Abstract Aims To develop machine‐learning algorithms for predicting the risk of a hospitalization or emergency department (ED) visit for opioid use disorder (OUD) (i.e. OUD acute events) in Pennsylvania Medicaid enrollees in the Opioid Use Disorder Centers of Excellence (COE) program and to evaluate the fairness of model performance across racial ...
Lingshu Xue, Ruofei Yin, Evan S. Cole, Wei‐Hsuan Lo‐Ciganic, Walid F. Gellad, Julie Donohue, Lu Tang   +6 more
wiley   +1 more source

A Pilot Assessment of Caregivers' and Patients' Perception of Naloxone Coprescribing in a Pediatric Sickle Cell Population. [PDF]

J Pediatr Pharmacol Ther
Ferengul EB, Oliveri LM, Briars L, Hsu LL, Reilly P, Hovey SW.   +5 more
europepmc   +1 more source

A double blind trial of naloxone in the treatment of acute stroke.

, 1984
Richard Fallis, Monika Fisher, Rogerio A. Løbo   +2 more
openalex   +1 more source

Dopamine D3 receptor blockade accelerates the extinction of opioid withdrawal‐induced drug‐seeking behaviours and alters microglia in dopaminoceptive nuclei

British Journal of Pharmacology, Volume 182, Issue 17, Page 4168-4185, September 2025.
Background and Purpose Among all drugs of abuse, opioids cause most of the deaths and treatment seeking. Despite abundant research in multifaceted therapeutic strategies, a high rate of relapse still characterises this condition. Dopamine D3 receptor antagonists combined with cue‐exposure therapies have been proposed to ameliorate the abused drugs ...
Aurelio Franco‐García, Victoria Gómez‐Murcia, M. Victoria Milanés, Cristina Núñez   +3 more
wiley   +1 more source

Community-Originated Research to Identify Access Gaps in Over-the-Counter Naloxone Availability in Connecticut Pharmacies. [PDF]

Harm Reduct J
Hill K, Canning P, Canning Z, Breen C, Evans L, Jenkins M, Nickel M, Plourd K, Heimer R.   +8 more
europepmc   +1 more source

USE OF NALOXONE IN OPIOID-INDUCED ANAPHYLACTOID REACTION

, 1988
Marios Z. Panos, S J Burnett, Brian Gazzard   +2 more
openalex   +1 more source

Influence of naloxone on the total capacitance vasculature of the dog. [PDF]

, 1985
L. B. Bell, Edward Maratea, D. L. Rutlen
openalex   +1 more source

‘It'd Be Nice to Know if You're About to Have Drain Cleaner’: A Qualitative Study of Preferred Drug Checking Service Features to Inform the Design of CheQpoint, Queensland's First Fixed‐Site Drug Checking Service

Drug and Alcohol Review, Volume 44, Issue 6, Page 1772-1785, September 2025.
ABSTRACT Introduction Drug checking is an important harm reduction service that allows service users to make an informed decision about drug use. In early 2024, Queensland became the second Australian jurisdiction to implement a fixed‐site drug checking service (CheQpoint).
Cheneal Puljević, Nina Pocuca, Brodie C. Dakin, Monica J. Barratt, Cameron Francis, Daniel Stjepanović, Sara Gill, Geoff Davey, Leanne Hides   +8 more
wiley   +1 more source

The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in Germany. [PDF]

Harm Reduct J
Fleißner S, Steimle L, Schäffer D, Werse B, Deimel D, Kuban M, Stöver H.   +6 more
europepmc   +1 more source

Responding to reports of nitazene toxicity in Australia

Medical Journal of Australia, Volume 222, Issue 5, Page 216-219, March 2025.
Brendan Clifford, Amy Peacock, Krista J Siefried, John Gobeil, Jennifer L Smith, Nadine Ezard   +5 more
wiley   +1 more source